Tackling tumor microenvironment through epigenetic tools to improve cancer immunotherapy

[1] Baylin SB(2016)Epigenetic determinants of cancer Cold Spring Harb Perspect Biol 8 a019505-8848

[2] Jones PA(2020)Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications Signal Transduct Target Ther 5 193-1786

[3] Song H(2018)Metabolic interactions in cancer: cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape Wiley Interdiscip Rev Syst Biol Med 10 e1397-45

[4] Liu D(2013)SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion J Transl Med. 11 111-1189

[5] Dong S(2017)Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival Mol Med Rep 16 8842-1078

[6] Zeng L(2012)Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer J Ovarian Res 5 24-2264

[7] Wu Z(2016)Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells Cell Rep 14 1774-9

[8] Zhao P(2013)Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells Mol Cell Biochem 378 39-2546

[9] Rinaldi G(2011)Loss of special at-rich binding protein 1 expression is a marker of poor survival in lung cancer J Thorac Oncol 6 1179-14

[10] Rossi M(2012)Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer Liver Int Liver Int 32 1064-2949

[1] Baylin SB(2016)Epigenetic determinants of cancer Cold Spring Harb Perspect Biol 8 a019505-8848

[2] Jones PA(2020)Epitranscriptomics and epiproteomics in cancer drug resistance: therapeutic implications Signal Transduct Target Ther 5 193-1786

[3] Song H(2018)Metabolic interactions in cancer: cellular metabolism at the interface between the microenvironment, the cancer cell phenotype and the epigenetic landscape Wiley Interdiscip Rev Syst Biol Med 10 e1397-45

[4] Liu D(2013)SATB1 is overexpressed in metastatic prostate cancer and promotes prostate cancer cell growth and invasion J Transl Med. 11 111-1189

[5] Dong S(2017)Elevated expression of SATB1 is involved in pancreatic tumorigenesis and is associated with poor patient survival Mol Med Rep 16 8842-1078

[6] Zeng L(2012)Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer J Ovarian Res 5 24-2264

[7] Wu Z(2016)Satb1 overexpression drives tumor-promoting activities in cancer-associated dendritic cells Cell Rep 14 1774-9

[8] Zhao P(2013)Silencing SATB1 inhibits proliferation of human osteosarcoma U2OS cells Mol Cell Biochem 378 39-2546

[9] Rinaldi G(2011)Loss of special at-rich binding protein 1 expression is a marker of poor survival in lung cancer J Thorac Oncol 6 1179-14

[10] Rossi M(2012)Upregulation of SATB1 promotes tumor growth and metastasis in liver cancer Liver Int Liver Int 32 1064-2949